Llilian Arzola-Martínez
Catherine Ptaschinski
Nicholas W. Lukacs- 1Department of Pathology, University of Michigan, Ann Arbor, MI, United States
- 2Mary H. Weiser Food Allergy Center (MHWFAC), University of Michigan, Ann Arbor, MI, United States
In recent years the increased incidence of food allergy in Western culture has been associated with environmental factors and an inappropriate immune phenotype. While the adaptive immune changes in food allergy development and progression have been well-characterized, an increase in innate cell frequency and activation status has also recently received greater attention. Early in prenatal and neonatal development of human immunity there is a reliance on epigenetic and metabolic changes that stem from environmental factors, which are critical in training the immune outcomes. In the present review, we discuss how trained immunity is regulated by epigenetic, microbial and metabolic factors, and how these factors and their impact on innate immunity have been linked to the development of food allergy. We further summarize current efforts to use probiotics as a potential therapeutic approach to reverse the epigenetic and metabolic signatures and prevent the development of severe anaphylactic food allergy, as well as the potential use of trained immunity as a diagnostic and management strategy. Finally, trained immunity is presented as one of the mechanisms of action of allergen-specific immunotherapy to promote tolerogenic responses in allergic individuals.
1. Introduction
Food allergy prevalence in western society has increased in the last several decades and is considered part of the “second wave” of the allergic epidemic (1). The increment in the number of worldwide cases have been associated with changes in lifestyle and modernization (cesarean delivery and western diet), access to antibiotics, urbanization and industrialization (2). Different hypotheses posit that these socioeconomics changes directly affect immune development through pathogen exposure (hygiene hypothesis) (3, 4) or that they are indirectly impacting immune development through the development of leaky epithelial barrier in the skin, airways, and gut mucosa (barrier hypothesis) (5, 6) resulting in microbiome dysbiosis, inappropriate immune responses and allergic diseases development.
The pathophysiology of food allergy is characterized by a poorly controlled/amplified Th2 inflammatory immune response to otherwise innocuous antigens (7). This type 2 immune response can provide protection from helminths, but is harmful in maintaining gut homeostasis in the context of food allergens (8). The mechanisms of allergic sensitization and response have been comprehensively reviewed elsewhere (7, 8) and involves an intricate crosstalk between structural and immune cells from both adaptative and innate arms of the immune system (Figure 1) (1, 8). The classical epitope-specific adaptive immunological memory has been widely explored in food allergy (9). In addition, an altered innate immune signature characterized by increased number and function of innate immune cells is present in food allergic patients early in life and can persist into adulthood (10, 11). However, the application of the new concept of trained innate immune responses in food allergy is just beginning to be investigated (12). Here we explore the studies done on the adaptability of the innate immune system in food allergy. While “food allergy” as an umbrella term encompasses many disease types, this review will focus on IgE-mediated, mast cell-driven anaphylactic allergic responses.
Figure 1. Th2 network in food allergy. During the sensitization phase, mature dendritic cells migrate to lymphoid organs to present the uptake food allergen to naïve T cells. A clonal expansion process is triggered resulting in the differentiation of allergen-specific Th2 cells that produce cytokines (IL4, IL5, IL9, IL13) and lead many aspects of allergic inflammatory responses. These Th2 derived cytokines (IL4 and IL13) initiated an IgE class switch recombination in naïve B cells, differentiation of plasma cells and allergen-specific IgE production. A subsequent encounter of dendritic cells with the same food allergen at the epithelial barrier will drive a type 2 immune response characterize by increased mucus and Th2 cytokines production, as well as recruitment and activation of effector cells (mast cells, basophils, eosinophils). This Th2 immune cascade is potentiated by the release of alarmins (IL25, IL33 and TSLP) from epithelial cells after damaged or been stressed by allergens, which upregulate stimulatory signals for T cell activation in dendritic cells and activate production of Th2 cytokines from ILCs. Food antigens that pass the epithelial barrier can bind to crosslinked allergen-specific IgE-FcεRI molecules on mast cells and basophils, leading to release of inflammatory mediators that produce the symptoms associated to a food allergic response. DC, dendritic cell; IL interleukin; ILC, innate lymphoid cell; MLN, mesenteric lymph node; TSLP, thymic stromal lymphopoietin. Created with Biorender.
2. Trained immunity
The innate immune system has long been defined as non-specific and lacking recall response, whereas the adaptive immune system forms memory responses against specific antigens. However, recent evidence has found that the innate immune system can indeed have “memory-like” features that program innate immune cells to respond based upon transcriptional activation. This phenomenon, termed “trained immunity,” generates an “educated” response to a subsequent encounter with a similar/distinct stimulus that activates common pathways. Epigenetic modifications and metabolic changes are two critical underlying mechanisms of long term trained innate immunity (13). The priming of the innate cell may result in a faster and stronger immune response, or conversely may lead to an attenuated, tolerogenic response (14, 15). The balance of these two contrasting program effects allows the innate immune system to respond appropriately in health and disease (16, 17). Understanding how to drive these different innate immune programs could be key to maintaining homeostasis and avoiding disease.
Recent studies have shown that protective innate immune responses can be stimulated by several well-known agents, including Bacillus Calmette-Guérin (BCG) vaccination (18), β-glucan (19, 20) and Candida albicans (14). Others exposures such as LPS (21), peptidoglycan (22), herpes virus (23), parasitic helminth (24, 25), and metabolic stimuli (26, 27) can also influence the development of trained immunity-like responses. The immunological phenotype associated with this programming can last for several months to years in individuals (28–30), often reinforced by continued or similar environmental stimuli. A variety of innate immune cells from the myeloid (monocytes, macrophages, dendritic cells, neutrophils and eosinophils) or lymphoid (natural killers [NK] cells, Innate lymphoid cells [ILC] 1 and 2) lineage go through epigenetic and metabolic reprogramming after bacterial, helminth and fungal infections, allergen stimulation, or vaccination (17, 19, 31, 32). Intriguingly, the life span of innate immune cells is relatively short (33), but recent studies have demonstrated that myeloid hematopoietic stem cells in the bone marrow (20, 34) and epithelial stem cells at the respiratory mucosal barrier (35) similarly develop a trained phenotype and stand ready to replenish immune and non-immune cells populations. Non-immune cells with a longer life span such as intestinal stromal cells, mesenchymal stromal cells, microglia, and fibroblast also exhibit epigenetic reprogramming that can contribute to the development of immune responses through production of mediators that affect local environments (36). In addition, the innate immune programing may be passed on in utero (37). Evidence suggests that prenatal maternal pathogen infections can shape the ultimate immune landscape in offspring, by changing T cell populations and altering the cytokine profile (38–40). Notably, BCG maternal vaccination status has a positive effect on child survival associated to the beneficial nonspecific effects of this live vaccine (41). In addition, maternal microbiome has arisen as one of the environmental factors that influences the vertical transmission of allergen-induced trained immunity (42). Overall, numerous studies provide evidence that maternal trained immunity could determine long-term immunological responses by modifying cellular phenotypes in offspring generations.
2.1. Trained immunity in food allergy
In the last several years, environmental and lifestyle factors have highly impacted the etiology of food allergy (7). Although trained immunity can result in an effective immune defense against infections, it can also trigger a hyper-inflammatory response that worsens an established inflammatory condition (16, 17) or contributes to the onset of a new pathological state (43). Some authors have associated food allergy with excessive trained immunity (43), and the loss of immune tolerance to food allergens early in life (44) or later in adulthood (45). In addition, food-allergen exposed allergic individuals often have a hyper-inflammatory innate immune response (12). Therefore, these associations suggest that trained immunity mechanisms are implicated in the development and persistence of food allergy. The role of trained immunity in the establishment of an allergic (Th2) vs. a tolerizing phenotype is not fully understood but it has been reported that changes in the abundance or functional status of crucial cells can influence local and systemic immune responses in food-sensitized individuals. The development of food allergy later in life was linked with an exaggerated inflammatory cytokine response after toll like receptor (TLR) stimulation in cord blood derived-mononuclear cells from allergic children compared to non-allergic controls in two birth cohorts (10, 46). The follow-up of one cohort showed that TLR responses were attenuated by the age of 5 years in the allergic subjects, which points to an abnormal early-stage maturation of the innate immune system in these children (10). The incubation of naive CD4+ T cells from cord blood coming from allergic donors with IL-1β+TGF-β and TNF-α+TGF-β cytokines resulted in an amplified type 2 immune responses (46). This experiment confirmed the association between early life innate immune hyperresponsiveness and predisposition to develop type 2 immune responses with ageing. An increase of the monocyte population in the cord blood was also associated with predisposition to develop allergen-specific type 2 responses (46). Another study found that monocytes from egg-allergic infants had an enhanced innate immune response to TLR stimulation and lower number of CD4+ regulatory T cells (47). In addition, a different cohort of challenge-confirmed egg-allergic 1-year-old infants showed increased numbers of circulating monocytes and dendritic cells compared with nonallergic controls. Also, cytokine production from sorted CD3-depleted cells (non-T cell fraction) was characterized by a high baseline concentration of the inflammatory cytokine IL-8, and lower production of Th1-associated (IL-12p70) and regulatory (IL-10) cytokines. These cytokines were further increased when cell from allergic patients were stimulated with LPS, suggesting the presence of a trained innate inflammatory response. The follow-up (at 2–4 years old) showed that infants who naturally develop clinical tolerance have a significant increase in the number of circulating myeloid DCs from baseline, while individuals with persistent egg allergy had an increased presence of monocytes (11). Combined, these studies suggest that innate immune cells population from food allergic individuals exhibit trained immunity features such as an increased myeloid circulatory population and hyperinflammatory phenotype (17), which may contribute to the DCs:T cell interaction and skew the balance in favor to allergic type 2 immune responses (48).
Future studies in food allergy need to be done describing other important cellular contributors to the allergic type 2 immune response. For example, ILC2s are a major source of IL-4, IL-5 and IL-13 cytokines that drive type 2 allergic inflammation by regulating (i) IgE production by B cells, (ii) mediating eosinophil differentiation, recruitment, and activation, and (iii) promoting mucus production and tissue remodeling in the epithelial cell layer, respectively (49). The activation of ILC2s is indirectly mediated by allergens and regulated by epithelial cell-derived cytokines including IL-25, thymic stromal lymphopoietin (TSLP), and IL-33, as well as lipids and neural signals (50). In a recent study using a peanut sensitized mouse model, it was shown that IgE-activated mast cells drive intestinal ILC2s expansion and IL-13 production in an IL-4Rα-dependent manner. In turn, ILC2 activation increased sensitivity to mast cells mediators leading to an amplified systemic anaphylaxis (51). Additionally, the tuft cell–ILC2 immune signaling loop in the small intestine has been proposed to amplified food allergy related anaphylactic symptoms (52). This circuit is initiated by the production of IL-25 by epithelial tuft cells (also called brush cells) which induce IL-13 production by ILC2s located in the lamina propria (53, 54). IL-13 production leads to epithelial remodeling marked by goblet and tuft cell hyperplasia, that feed-forward to ILC2s activation (53, 54). Other Th2 cytokines produced by ILC2s, such as IL-4 stops the production of regulatory T cells (55) and promotes intestinal mast cell accumulation resulting in IgE-mast cells activation and increased gut permeability worsening allergic responses (56). The accumulation of secretory cells such as tuft cells also contribute to food induced anaphylactic response by promoting secretory-antigen passages in the small intestine, facilitating food allergens to cross the epithelial barrier and contact IgE inducing mast cell degranulation (57). In addition, tuft cells are considered epithelial chemosensory cells specialized in monitor microbial metabolites, such as succinate. Microbiome modification after deleterious environmental exposures have been associated with elevated levels of succinate in the lumen, which boosts type 2 immunity mediated by tuft cells, predisposing the host and increasing the reaction severity to food allergens (52).
While less is known about the innate training of cells such as ILC2s and epithelial cells in the intestine, more work has been done to understand these cells and their role in the development of Th2 responses in the airways. In the lung, ILC2s are trained by exposure to allergens and IL-33. These allergen-primed ILC2s acquired non-specific memory-like type 2 immune responses, that could explain the response to multiple allergens in asthmatic individuals (49, 50). On the other hand, the presence of retinoic acid and IL-33 direct the generation of immunosuppressive trained ILC2s that produce IL-10 cytokine, showing the importance of the local cytokine environment to regulate immune responses in these cells (50). In the same way, it was shown that ex vivo cultures of basal progenitors of airway epithelial cells conserve intrinsic memory of IL-4/IL-13 exposure, contributing to the disruption of the epithelial barrier and persistence of allergen-driven type 2 inflammation in the airway (35). Other cellular players in type 2 inflammatory responses, such as macrophages (58) and eosinophils (59, 60) have been reported to also undergo innate training after challenge with allergen and parasite infection. Furthermore, macrophages experienced metabolic and epigenetic reprograming that contributes to the chronic type 2 airway inflammatory landscape in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) (61). Determining whether similar trained innate immune responses occur in the gut will be critical to understanding the potential to develop therapeutic targets and preventative approaches to food allergy.
3. Epigenetic and metabolic reprograming in food allergy
The potent transcriptional response to allergens that characterize innate trained immunity (15) is accompanied by epigenetic regulation of genes related to immune function, chromatin remodeling and alteration of overall metabolic activity (13, 62). These two mechanisms (epigenetic and metabolic) work together to fine-tune the appropriated innate immune response.
3.1. Epigenetics
While genetic variants associated with food allergy still need to be carefully studied, it is clear that genetic influence in food allergy has a dominant role. Candidate-gene and genome-wide association studies (GWAS) have revealed new and old correlations and a diversity in the loci variants (polygenetic) associated with food allergy (63–65). However, the variety of food allergy phenotypes, clinical manifestations and responses cannot be only attributed to genetic predisposition. This immune disorder is a result of a complex interplay between the gene pool and exposure to different environmental factors (66–68). Epigenetic mechanisms can mediate the bidirectional communication between genes and environment and therefore contribute to the disease development and course (66). Preliminary evidence suggested that the exaggerated Th2 immune response, commonly share by allergic diseases, is tightly regulated by epigenetic mechanisms that promotes the immediate release of Th2 cytokines in response to allergens, and the heritability of the Th2 phenotype (69).
The epigenetic modification of the chromatin reversibly regulates gene transcription without altering the nucleotide sequence in the genome (66). In general, the control of transcriptional programs at the epigenetic level can be exerted by three different mechanisms. Two of them involve the addition or removal of biochemical groups by enzymes, directly modifying the DNA (methylation) or the tail of core histones (acetylation, methylation, phosphorylation, biotinylating, etc.) (70). DNA methylation involves the addition of methyl groups to cysteine in CG rich regions, which is instructive for transcriptional silencing (71). Lastly, small, non-coding RNA molecules known as microRNAs (miRNA) are another mechanism of epigenetic modification and does not involve enzymatic regulation. Instead, miRNA molecules are involved in the post-transcriptional regulation of gene expression during allergic immune responses in epithelial and immune cells and act by binding to the 3′ untranslated region of an mRNA molecule, thereby destabilizing the mRNA and leading to its degradation (72). Together, the epigenetic machinery is used to stabilize cellular “memory” and influence in the cellular fate and identity (73). Given the relatively sudden rise in allergy in general and food allergy specifically, the changes in environmental epigenetic modification of immune gene transcription is a logical mechanism leading to enhanced disease incidence. For example, early-life differential DNA methylation patterns in allergic individuals is currently being investigated as a potential childhood biomarker (74).
Research on the epigenetics of food allergy is very limited. Only a few studies have shown that the immune response in food allergy is under epigenetic regulation. DNA methylation patterns in childhood food allergy is by far the most studied epigenetic mark. Previously, changes in DNA methylation were connected to aberrant gene transcription and enhanced risk of developing allergic airway disease (75). Recent studies have suggested DNA methylation as a potential epigenetic mechanism that may be diagnostic and could direct therapeutic intervention in food allergy (76, 77). To date, numerous studies have looked at the role of DNA methylation in allergic and tolerogenic responses in humans and in mouse models. These studies have focused on differential DNA methylation patterns in the promoter regions of genes associated with Th1 and Th2 cells, as well as on regulatory T cells. For example, Canani et al. (78) explored the link between DNA methylation and gene expression in peripheral blood mononuclear cells of children with active IgE-mediated cow's milk allergy, tolerant children, and healthy controls. They found opposing methylation patterns in the promoter regions of Th1 and Th2 cytokines genes in children with active IgE-mediated cow's milk allergy compared to tolerant children and healthy controls. In allergic subjects they found a correlation between the promoter methylation pattern and serum cytokine expression. In addition, Petrus et al. studied a cohort of Dutch children and found that the hypermethylation in the cow's milk allergic group was reestablished to control levels in allergic children who develop tolerance, indicating a potentially transient/reversible nature of epigenetic modification (79). The FoxP3 gene, that codifies a member of the forkhead transcription factor family, is epigenetically regulated in Treg cells (Treg) during food allergy (46, 80, 81), being less transcriptionally active in allergic children (80, 82). Thus, specific regulation of gene expression by DNA methylation appears to correlate to food allergic disease development. These studies and others involving DNA methylation of T cell responses in food allergy are summarized in Table 1. Although most of the studies explore DNA methylation profile as a promising biomarker, other mechanisms of epigenetic regulation are also implicated in food allergy. In one study, the acquired tolerance associated with raw milk consumption in a murine model of OVA-induced food allergy was linked to a lower histone acetylation of Th2 genes in splenocyte-derived CD4+ T cells (83). Furthermore, the protective effect of early life consumption of raw cow's milk and breastfeeding on the development of allergic disease have been associated with other epigenetic mechanisms, such as miRNA, contained in extracellular vesicles or exosomes from human and cow's milk (84). miRNA have been implicated in the allergic and anti-helminthic immune gene regulation in Th2 cells (85) and the induction of Treg function (86, 87) during the preventive response to allergy. However, miRNA gene regulation is still an epigenetic mechanism largely unexplored in food allergy. So far, a total of 16 miRNA have been found to be differentially regulated in peripheral blood mononuclear cells obtained from cow milk allergic children compared to healthy controls. Specifically, miR-1931-5p was the most downregulated miRNA in allergic children and was found to be a post-transcriptional regulator of IL4 (88). Thus, miR-1931-5p was proposed to be a novel diagnostic and therapeutic target for cow milk allergy in infants.
Table 1. DNA methylation of T cells in allergic diseases.
While the focus of most studies has been on the T cell responses, there are several other targets that are likely very relevant. B cells are another component of the acquired immunity that can be epigenetically modified in food allergy. These cells produce allergen-specific immunoglobulins such as IgE that mediates hypersensitivity reactions, having an important role in the allergic responses (89). The epigenomic and transcriptomic profiles of B cells purified from adolescent patients with peanut allergy, multi-food allergy, and non-allergic controls showed differences in the methylation pattern and gene expression that differentiates a food allergic individual from healthy controls. In addition, peanut allergy and multi-food allergy patients had group-specific epigenetic modifications in promoter regions recognized by transcription factors that regulated B- and T-cell development, B-cell lineage determination, and TGFβ signaling (90). This study highlights epigenetic modifications as a promising technique to distinguish between individuals with single-food allergy and multi-food allergy. Further epigenetic studies in food allergy-related innate immune cells are scarce, although it has been found that mast cell activation during the effector phase of a food allergy immune response can be regulated through altered histone acetylation (91). The pretreatment of bone marrow derived mast cells with the histone deacetylase inhibitor trichostatin A (TSA) in vitro decreased transcriptional activity of key genes involved in the degranulation and inflammation process including FcεRI, Il4, Il6, Il13 and Tnfα. The treatment of OVA-induced food allergic mice with TSA attenuated the development of food allergy symptoms and mast cell activation (91). In a recent study that examined epigenetic regulation, authors observed significant decreases in DNA methylation levels for the genes IL1β and IL6 in peripheral blood mononuclear cells of peanut allergic patients compared with non-allergic individuals (92). They also found increased secretion of proinflammatory cytokines in food-allergic compared with non-allergic participants after stimulation.
Epigenetics in food allergy is still a field in the early stages of development. Additional descriptive and functional studies may help to improve our understanding of gene expression regulation by epigenetic mechanisms and how this expression patterns may correlate with clinical outcomes in the context of food allergy. Modification of the epigenetic landscape is a promising novel strategy for prediction, prevention, and treatment of this immune disease.
3.2. Importance of microbiota and probiotics to shape the epigenome in food allergy
While genetics can predispose individuals, environmental factors appear to participate in the development and/or maintenance of allergic disorders (67, 68). The diversity of microorganisms colonizing the surface and cavities of the host body is a major environmental factor that can shape the epigenome (93). These commensal bacteria use bioactive molecules produced by microbial metabolism (short chain fatty acid, vitamins, polyphenols, polyamines) and structural components (LPS, peptidoglycan, flagellin) as messengers to interact with the host local (monocytes/macrophages and NK cells) or systemic (hematopoietic progenitors in bone marrow) immune cells (94). It has been proposed that this direct/indirect communication could change the immune cells' epigenetic and metabolic programs and enhance their response to subsequent antigen stimulation (94). An imbalance in the composition and/or function of the gut microbiota, called dysbiosis, has been found to be detrimental for the commensal interaction between host immune system and microbes (95), and led to inflammatory disorders such as food allergy (96). Early life probiotic supplementation has emerged as a useful strategy to shape the gut microbiota and to prevent the development of allergic diseases (95). In a mouse model, prenatal and postnatal consumption of probiotic fermented milk containing the probiotic bacteria strain Lactobacillus casei DN-114001 positively change the bacterial colonization pattern in the newborn and stimulated their mucosal immunity (97). Cortes-Perez N. et al. investigated the ability of probiotics to induce trained immunity. They associated the systemic protective effects related to probiotic oral consumption with trained innate immune cells reaching other sites of the common mucosal system, as well as translation of microbial components to bone marrow where they can stimulate myelopoiesis and long-term immune effects (98). However, the desired immunological response depended on the selection and combination of probiotic strains, as different strains can drive either proinflammatory or anti-inflammatory responses (99). Mainly lactobacilli and bifidobacterial lactic acid bacteria have been tested to determine whether probiotics can be used in the prevention of allergies (95). However, conflicting results have prevented them from being systematically used for the prevention of food allergy (95).
A few studies have explored the impact of probiotics on epigenetics and host immunity in the context of food allergy. Differential epigenetic modulation was exerted by a variety of dietary interventions in IgE-mediated cow's milk allergy in children. The patients receiving a hydrolyzed casein formula with the probiotic Lactobacillus rhamnosus GG showed a differential DNA methylation rate in IL4, IL5, IL10, and IFNγ compared with children that received soy formula (100), reverting to the methylation profile observed by Canani et al. in cow's milk allergic children (78). Also, the probiotic administration differentially modulated microRNA expression, including miR-155, -146a, -128 and -193a (100), all of which can have immune altering effects. Another study, in which children with cow's milk allergy were also supplemented with the hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG, an upregulation of the demethylation rate on FoxP3 gene was found, indicating that this probiotic was able to enhance tolerogenic Treg function (80). Peripheral mononuclear blood cells incubated in vitro with the protein fraction of the extensively hydrolyzed casein formula also increased the DNA demethylation rate of the FoxP3 gene, as well as IL10 and IFNγ production and increased CD4+ FOXP3+ Treg number (101). Both investigations associated the development of cow's milk tolerance, with changes in the methylation epigenetic profile in the FoxP3 gene (80, 101). In addition, the Lactobacillus rhamnosus GG supplemented formula increased butyrate-producing bacterial strains in the gut of food allergic infants (102). The metabolite butyrate can inhibit histone deacetylase activity (103), which stimulates the production and function of regulatory T cells (104). Together, these studies suggest the ability of probiotics to promote a tolerogenic environment by modifying cell immunological program and responses.
3.3. Metabolism
The epigenetic and transcriptional reprogramming inherent to trained innate immunity is also accompanied by metabolic alterations (105). During trained immunity the interaction of microbial ligands to specific receptors can result in the differential activation of cellular metabolic pathways (43). The innate cells' energetic metabolic reprograming includes glucose metabolism (glycolysis, oxidative phosphorylation, TCA cycle and pentose phosphate), cholesterol (mevalonate), fatty acid (synthesis and β-oxidation) and glutaminolysis pathways (13, 43). A cellular-specific energetic metabolic shift between oxidative phosphorylation (OXPHOS) and glycolysis facilitates the activation of innate immune cells and their ability to function as trained cells (13, 16). For trainable cells such as macrophages, retaining metabolic diversity is crucial to effectively respond to secondary challenges and depends on the stimulus used to activate/polarize these cells. An elegant study from Lundahl et al. demonstrated that acute alternative activation with Th2 cytokines (IL-4 and IL-13) programs bone marrow-derived macrophages to enhance pro-inflammatory cytokine secretion and killing capacity in response to a secondary mycobacterial infection. These trained macrophages shifted towards a pro-inflammatory cytokine profile previously associated with classically activated macrophages but retain OXPHOS metabolism characteristic of alternative activation, suggesting that OXPHOS can be important for pro-inflammatory responses (106). Other authors pointed out that alternative activated macrophages maintain their metabolic versatility (107), crucial for skewing towards an anti-mycobacterium response. In addition, proinflammatory cytokine secretion by trained macrophages was abrogated by inhibition of DNA methylation, although epigenetics changes were not fully addressed by the authors in this investigation (106).
Nevertheless, little is known about the metabolic reprogramming of innate immune cells in a Th2 driven environment such as food allergy. A study that investigated naïve CD4+ T cell activation in a pediatric cohort of egg allergy subjects compared to non-atopic controls found that pathways related to fatty acid metabolism (cholesterol homeostasis) were significantly upregulated in allergic individuals (108). These authors also detected changes in DNA methylation in genes involved in the metabolic regulation of oxidative phosphorylation and glycolysis (RPTOR, PIK3D, MAPK1, FOXO1) which were upregulated in the allergic children (108). Hong et al. used KEGG database to analyze more than 300 genes that had at least one differentially methylated position associated with milk protein allergy in whole blood samples. They identified three enriched metabolic pathways related with carbohydrate metabolism (starch & sucrose metabolism, fructose and mannose metabolism) and antibiotic biosynthesis (butirosin and neomycin biosynthesis), that shares hexokinase genes important for the glucose metabolism (109). Finally, Khader et al. showed that accumulation of substrates of the tricarboxylic acid cycle (succinate and fumarate) can indirectly impact the histone methylation through the inhibition of demethylase activity (110). These results support previous suggestions that epigenetic changes and metabolism are reciprocally regulated (111) and crucial for the development of a trained phenotype.
4. Trained immunity as a therapeutic strategy in food allergy
There is contrasting evidence that trained immunity mediates a deleterious effect and atypical innate immune responses after exposure to stimuli in food allergy (47), and it is important to understand the mechanisms underlaying trained immunity if there is to be a potential for the future development of novel therapeutic strategies to prevent and treat allergic diseases (48, 112). Trained immunity is seen as a possible mechanism to explain the non-specific effects associated to some vaccines based on attenuated and/or inactivated pathogens that trigger pattern recognition receptors (PPR) (113). Trained immunity-based vaccines confer a broad protection by impacting innate immune cells and promoting non-specific response, while modulating specific adaptative T cell responses (30, 114). For example, early life vaccination with BCG has been linked with an enhanced Th1 immune response (115) and downmodulation of the Th2 allergic phenotype (116). However, other authors could not associate BCG vaccination with protection from allergic airway disease (117, 118) or suspected sensitization/food allergy (119). Another study found that whole cell killed pertussis vaccine was associated with protection against allergic disorders, including food allergy (120). Thus, a pioneering use of trained immunity could be related to its applicability in allergic prevention and treatment, acting as an immune system regulator. Recent investigations suggest that generation of novel vaccines with allergens for allergen specific immunotherapy (AIT), could imprint a tolerogenic phenotype by promoting metabolic and epigenetic reprogramming; and restore levels of ILCs, monocytes, dendritic cells and macrophages contributing to the establishment of a healthy immune responses to allergens (31, 121, 122). As well, new findings related to sublingual and subcutaneous AIT showed that the prolonged exposition to allergen induces the differentiation of naïve ILC2s into IL-10+ILC2 cells, which contribute to immune tolerance by restoring epithelial cell barrier integrity and repressing allergic Th2 responses (123, 124). Traditionally the effectiveness of AIT to treat IgE-mediated allergies was associated with increments in the production of allergen-specific IgG antibodies that shifts the recognition of allergens away from IgE, reducing the symptoms of allergic inflammation with long-lasting effects (112). For example, in a peanut-sensitized mice model, immunotherapy with virus-like particle (a molecular form of AIT) coupled to a single peanut allergen induced specific IgG antibodies, that conferred protection against anaphylaxis after systemic challenge with the whole peanut extract and diminished local reactions after skin prick tests (125). AIT also induce regulatory T and B cells, suppress Th2 and skew towards Th1 cells differentiation (123). However, the capacity of next generation of AIT allergen vaccines to restore/modulate innate immune responses in addition to regulate adaptative immune responses needs to be definitively demonstrated. The use of AIT as a preventive and/or therapeutic approach to reduce allergen-induced symptoms during allergic inflammatory diseases have been review elsewhere (112). Overall, understanding how AIT-induced trained immunity to reestablish innate immune homeostasis may lead to the use of AIT as a preventive strategy in allergic diseases.
5. Final thoughts
Initial studies have implicated trained immune responses in the establishment, development and persistency of food allergy. Growing evidence indicates that early life epigenetic and metabolic reprograming underlies the increased responsiveness to food allergens. The changes in cellular metabolism and the epigenetic program contribute to the regulation of the immune function and correlate with clinical outcomes (Figure 2). Longitudinal studies are needed to characterize the temporal relationship of the epigenetic and metabolic status of diverse immune cells population in this allergic disease. This approach will help to validate the potential efficacy and optimal use of innate cell therapy for regulating the frequency and/or activation status as an accurate preventive strategy in food allergy. In addition, the use of probiotics to selectively modulate intestinal microbiota to produce dynamic changes in the epigenetic landscape and metabolic pathways that regulates the immune response may be useful for altering food allergy development and severity. More studies are needed to elucidate if the protective and immunomodulatory effects in different mucosal sites reported for probiotic supplementation are related to an effective trained immune response, and how understanding of this response may be used in the prevention and treatment of anaphylactic food allergy.
Figure 2. Epigenome and metabolic modification early in life are determining factors for the establishment of food allergy or for a tolerant trained immune phenotype. Food allergy can be triggered by the interaction of genes with the environment. Early life exposures to microbial infection, vaccines, probiotics and altered gut microbiota can shape the epigenetic and metabolic program, the components of which can be reciprocally regulated. The control of the transcriptional landscape by DNA methylation, histone modifications and non-coding RNA molecules, as well as changes in the energetic metabolic, leads to activation of local immune cells and hematopoietic progenitors in bone marrow as functional trained cells. Created with Biorender.
Author contributions
LA and NL conceived the idea. LA, CP and NL wrote the manuscript. All authors contributed to the article and approved the submitted version.
Funding
This work was financed by Mary H. Weiser Food Allergy Center (MHWFAC), University of Michigan, Ann Arbor, MI, USA.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Tordesillas L, Berin MC, Sampson HA. Immunology of food allergy. Immunity. (2017) 47(1):32–50. doi: 10.1016/j.immuni.2017.07.004
2. Renz H, Skevaki C. Early life microbial exposures and allergy risks: opportunities for prevention. Nat Rev Immunol. (2021) 21(3):177–91. doi: 10.1038/s41577-020-00420-y
3. von Mutius E, Vercelli D. Farm living: effects on childhood asthma and allergy (vol 10, pg 861, 2010). Nat Rev Immunol. (2019) 19(9):594. doi: 10.1038/s41577-019-0199-3
4. Strachan DP. Hay-fever, hygiene, and household size. Brit Med J. (1989) 299(6710):1259–60. doi: 10.1136/bmj.299.6710.1259
5. Pothoven KL, Schleimer RP. The barrier hypothesis and oncostatin M: restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease. Tissue Barriers. (2017) 5(3):e1341367. doi: 10.1080/21688370.2017.1341367
6. Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. (2021) 21(11):739–51. doi: 10.1038/s41577-021-00538-7
7. Yu W, Freeland DMH, Nadeau KC. Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol. (2016) 16(12):751–65. doi: 10.1038/nri.2016.111
8. Bruton K, Koenig JFE, Phelps A, Jordana M. Perturbations to homeostasis in experimental models revealed innate pathways driving food allergy. Front Immunol. (2020) 11:603272. doi: 10.3389/fimmu.2020.603272
9. Kanagaratham C, El Ansari YS, Lewis OL, Oettgen HC. Ige and Igg antibodies as regulators of mast cell and basophil functions in food allergy. Front Immunol. (2020) 11:603050. doi: 10.3389/fimmu.2020.603050
10. Tulic MK, Hodder M, Forsberg A, McCarthy S, Richman T, D'Vaz N, et al. Differences in innate immune function between allergic and nonallergic children: new insights into immune ontogeny. J Allergy Clin Immun. (2011) 127(2):470–8.e1. doi: 10.1016/j.jaci.2010.09.020
11. Neeland MR, Koplin JJ, Dang TD, Dharmage SC, Tang ML, Prescott SL, et al. Early life innate immune signatures of persistent food allergy. J Allergy Clin Immun. (2018) 142(3):857. doi: 10.1016/j.jaci.2017.10.024
12. Imran S, Neeland MR, Shepherd R, Messina N, Perrett KP, Netea MG, et al. A potential role for epigenetically mediated trained immunity in food allergy. iScience. (2020) 23(6):101171. doi: 10.1016/j.isci.2020.101171
13. Dominguez-Andres J, Netea MG. Long-term reprogramming of the innate immune system. J Leukocyte Biol. (2019) 105(2):329–38. doi: 10.1002/Jlb.Mr0318-104r
14. Netea MG, Joosten LAB, Latz E, Mills KHG, Natoli G, Stunnenberg HG, et al. Trained immunity: a program of innate immune memory in health and disease. Science. (2016) 352(6284):aaf1098. doi: 10.1126/science.aaf1098
15. Hajishengallis G, Li XF, Mitroulis I, Chavakis T. Trained innate immunity and its implications for mucosal immunity and inflammation. Oral Mucosal Immun Microbiome. (2019) 1197:11–26. doi: 10.1007/978-3-030-28524-1_2
16. Bindu S, Dandapat S, Manikandan R, Dinesh M, Subbaiyan A, Mani P, et al. Prophylactic and therapeutic insights into trained immunity: a renewed concept of innate immune memory. Hum Vacc Immunother. (2022) 18(1):2040238. doi: 10.1080/21645515.2022.2040238
17. Netea MG, Dominguez-Andres J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. (2020) 20(6):375–88. doi: 10.1038/s41577-020-0285-6
18. Covian C, Rios M, Berrios-Rojas RV, Bueno SM, Kalergis AM. Induction of trained immunity by recombinant vaccines. Front Immunol. (2021) 11:611946. doi: 10.3389/fimmu.2020.611946
19. Moorlag SJCFM, Khan N, Novakovic B, Kaufmann E, Jansen T, van Crevel R, et al. Beta-glucan induces protective trained immunity against Mycobacterium Tuberculosis infection: a key role for Il-1. Cell Rep. (2020) 31(7):107634. doi: 10.1016/j.celrep.2020.107634
20. Mitroulis I, Ruppova K, Wang BM, Chen LS, Grzybek M, Grinenko T, et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell. (2018) 172(1–2):147. doi: 10.1016/j.cell.2017.11.034
21. Liu GY, Liu Y, Lu Y, Qin YR, Di GH, Lei YH, et al. Short-term memory of danger signals or environmental stimuli in mesenchymal stem cells: implications for therapeutic potential. Cell Mol Immunol. (2016) 13(3):369–78. doi: 10.1038/cmi.2015.11
22. Krahenbuhl JL, Sharma SD, Ferraresi RW, Remington JS. Effects of muramyl dipeptide treatment on resistance to infection with toxoplasma-gondii in mice. Infect Immun. (1981) 31(2):716–22. doi: 10.1128/Iai.31.2.716-722.1981
23. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. (2007) 447(7142):326–9. doi: 10.1038/nature05762
24. Chen F, Wu WH, Millman A, Craft JF, Chen E, Patel N, et al. Neutrophils prime a long-lived effector macrophage phenotype that mediates accelerated helminth expulsion. Nat Immunol. (2014) 15(10):938–46. doi: 10.1038/ni.2984
25. Yasuda K, Adachi T, Koida A, Nakanishi K. Nematode-infected mice acquire resistance to subsequent infection with unrelated nematode by inducing highly responsive group 2 innate lymphoid cells in the lung. Front Immunol. (2018) 9:2132. doi: 10.3389/fimmu.2018.02132
26. Christ A, Gunther P, Lauterbach MAR, Duewell P, Biswas D, Pelka K, et al. Western diet triggers Nlrp3-dependent innate immune reprogramming. Cell. (2018) 172(1–2):162–75.e14. doi: 10.1016/j.cell.2017.12.013
27. Arts RJ, Novakovic B, Ter Horst R, Carvalho A, Bekkering S, Lachmandas E, et al. Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity. Cell Metab. (2016) 24(6):807–19. doi: 10.1016/j.cmet.2016.10.008
28. Rieckmann A, Villumsen M, Sorup S, Haugaard LK, Ravn H, Roth A, et al. Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a danish case-cohort study 1971−2010. Int J Epidemiol. (2017) 46(2):695–705. doi: 10.1093/ije/dyw120
29. Nankabirwa V, Tumwine JK, Mugaba PM, Tylleskar T, Sommerfelt H, Grp P-ES. Child survival and Bcg vaccination: a community based prospective cohort study in Uganda. Bmc Public Health. (2015) 15:175. doi: 10.1186/s12889-015-1497-8
30. Kleinnijenhuis J, Quintin J, Preijers F, Benn CS, Joosten LA, Jacobs C, et al. Long-lasting effects of Bcg vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun. (2014) 6(2):152–8. doi: 10.1159/000355628
31. Eljaszewicz A, Ruchti F, Radzikowska U, Globinska A, Boonpiyathad T, Gschwend A, et al. Trained immunity and tolerance in innate lymphoid cells, monocytes, and dendritic cells during allergen-specific immunotherapy. J Allergy Clin Immunol. (2021) 147(5):1865–77. doi: 10.1016/j.jaci.2020.08.042
32. Hartung F, Esser-von Bieren J. Trained immunity in type 2 immune responses (sept, 10.1038/S41385-022-00557-0, 2022). Mucosal Immunol. (2022) 15(6):1447. doi: 10.1038/s41385-022-00568-x
33. Patel AA, Zhang Y, Fullerton JN, Boelen L, Rongvaux A, Maini AA, et al. The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. J Exp Med. (2017) 214(7):1913–23. doi: 10.1084/jem.20170355
34. Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, et al. Bcg educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell. (2018) 172(1–2):176. doi: 10.1016/j.cell.2017.12.031
35. Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. (2018) 560(7720):649. doi: 10.1038/s41586-018-0449-8
36. Hamada A, Torre C, Drancourt M, Ghigo E. Trained immunity carried by non-immune cells. Front Microbiol. (2018) 9:3225. doi: 10.3389/fmicb.2018.03225
37. Katzmarski N, Dominguez-Andres J, Cirovic B, Renieris G, Ciarlo E, Le Roy D, et al. Transmission of trained immunity and heterologous resistance to infections across generations. Nat Immunol. (2021) 22(11):1382. doi: 10.1038/s41590-021-01052-7
38. Lim AI, McFadden T, Link VM, Han SJ, Karlsson RM, Stacy A, et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. (2021) 373(6558):eabf3002. doi: 10.1126/science.abf3002
39. Gee S, Chandiramani M, Seow J, Modestini C, Das A, Doores KJ, et al. The legacy of maternal Sars-Cov-2 infection on the immunology of the neonate. Nat Immunol. (2021) 22(12):1490. doi: 10.1038/s41590-021-01049-2
40. Hong M, Sandalova E, Low D, Gehring AJ, Fieni S, Amadei B, et al. Trained immunity in newborn infants of Hbv-infected mothers. Nat Commun. (2015) 6:6588. doi: 10.1038/ncomms7588
41. Berendsen MLT, Oland CB, Bles P, Jensen AKG, Kofoed PE, Whittle H, et al. Maternal priming: bacillus calmette-guerin (Bcg) vaccine scarring in mothers enhances the survival of their child with a Bcg vaccine scar. J Pediat Inf Dis Soc. (2020) 9(2):166–72. doi: 10.1093/jpids/piy142
42. West CE, Renz H, Jenmalm MC, Kozyrskyj AL, Allen KJ, Vuillermin P, et al. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. J Allergy Clin Immun. (2015) 135(1):3–14. doi: 10.1016/j.jaci.2014.11.012
43. Mulder WJM, Ochando J, Joosten LAB, Fayad ZA, Netea MG. Therapeutic targeting of trained immunity. Nat Rev Drug Discov. (2019) 18(7):553–66. doi: 10.1038/s41573-019-0025-4
44. Hong X, Wang X. Early life precursors, epigenetics, and the development of food allergy. Semin Immunopathol. (2012) 34(5):655–69. doi: 10.1007/s00281-012-0323-y
45. Mahdavinia M. Food allergy in adults: presentations, evaluation, and treatment. Med Clin North Am. (2020) 104(1):145–55. doi: 10.1016/j.mcna.2019.08.008
46. Zhang YX, Collier F, Naselli G, Saffery R, Tang MLK, Allen KJ, et al. Cord blood monocyte-derived inflammatory cytokines suppress Il-2 and induce nonclassic “T(H)2-type” immunity associated with development of food allergy. Sci Transl Med. (2016) 8(321):321ra8. doi: 10.1126/scitranslmed.aad4322
47. Neeland MR, Novakovic B, Dang TD, Perrett KP, Koplin JJ, Saffery R. Hyper-inflammatory monocyte activation following endotoxin exposure in food allergic infants. Front Immunol. (2020) 11:567981. doi: 10.3389/fimmu.2020.567981
48. Martin-Cruz L, Sevilla-Ortega C, Angelina A, Dominguez-Andres J, Netea MG, Subiza JL, et al. From trained immunity in allergy to trained immunity-based allergen vaccines. Clin Exp Allergy. (2023) 53(2):145–55. doi: 10.1111/cea.14261
49. Martinez-Gonzalez I, Matha L, Steer CA, Ghaedi M, Poon GFT, Takei F. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity. (2016) 45(1):198–208. doi: 10.1016/j.immuni.2016.06.017
50. Ebihara T, Tatematsu M, Fuchimukai A, Yamada T, Yamagata K, Takasuga S, et al. Trained innate lymphoid cells in allergic diseases. Allergol Int. (2021) 70(2):174–80. doi: 10.1016/j.alit.2020.11.007
51. Burton OT, Tamayo JM, Stranks AJ, Miller S, Koleoglou KJ, Weinberg EO, et al. Ige promotes type 2 innate lymphoid cells in murine food allergy. Clin Exp Allergy. (2018) 48(3):288–96. doi: 10.1111/cea.13075
52. Nico KF, Tyner MDW, Howitt MR. Succinate and tuft cells: how does this sensory process interface with food allergy? J Allergy Clin Immun. (2022) 150(3):580–2. doi: 10.1016/j.jaci.2022.07.016
53. Nadjsombati MS, McGinty JW, Lyons-Cohen MR, Jaffe JB, DiPeso L, Schneider C, et al. Detection of succinate by intestinal tuft cells triggers a type 2 innate immune circuit. Immunity. (2018) 49(1):33. doi: 10.1016/j.immuni.2018.06.016
54. von Moltke J, Ji M, Liang HE, Locksley RM. Tuft-cell-derived Il-25 regulates an intestinal Ilc2-epithelial response circuit. Nature. (2016) 529(7585):221–5. doi: 10.1038/nature16161
55. Rivas MN, Burton OT, Oettgen HC, Chatila T. Il-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function. J Allergy Clin Immun. (2016) 138(3):801. doi: 10.1016/j.jaci.2016.02.030
56. Leyva-Castillo JM, Galand C, Kam C, Burton O, Gurish M, Musser MA, et al. Mechanical skin injury promotes food anaphylaxis by driving intestinal mast cell expansion. Immunity. (2019) 50(5):1262. doi: 10.1016/j.immuni.2019.03.023
57. Noah TK, Knoop KA, McDonald KG, Gustafsson JK, Waggoner L, Vanoni S, et al. Il-13-induced intestinal secretory epithelial cell antigen passages are required for ige-mediated food-induced anaphylaxis. J Allergy Clin Immun. (2019) 144(4):1058. doi: 10.1016/j.jaci.2019.04.030
58. Lechner A, Henkel FDR, Hartung F, Bohnacker S, Alessandrini F, Gubernatorova EO, et al. Macrophages acquire a tnf-dependent inflammatory memory in allergic asthma. J Allergy Clin Immun. (2022) 149(6):2078–90. doi: 10.1016/j.jaci.2021.11.026
59. Gazzinelli-Guimaraes PH, Prado RD, Ricciardi A, Bonne-Annee S, Sciurba J, Karmele EP, et al. Allergen presensitization drives an eosinophil-dependent arrest in lung-specific helminth development. J Clin Invest. (2019) 129(9):3686–701. doi: 10.1172/Jci127963
60. Ahrends T, Aydin B, Matheis F, Classon CH, Marchildon F, Furtado GC, et al. Enteric pathogens induce tissue tolerance and prevent neuronal loss from subsequent infections. Cell. (2021) 184(23):5715. doi: 10.1016/j.cell.2021.10.004
61. Haimerl P, Bernhardt U, Schindela S, Henkel FDR, Lechner A, Zissler UM, et al. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease. J Allergy Clin Immun. (2021) 147(2):587–99. doi: 10.1016/j.jaci.2020.04.064
62. Canas JA, Nunez R, Cruz-Amaya A, Gomez F, Torres MJ, Palomares F, et al. Epigenetics in food allergy and immunomodulation. Nutrients. (2021) 13(12):4345. doi: 10.3390/nu13124345
63. Johansson E, Mersha TB. Genetics of food allergy. Immunol Allergy Clin North Am. (2021) 41(2):301–19. doi: 10.1016/j.iac.2021.01.010
64. Suaini NHA, Wang Y, Soriano VX, Martino DJ, Allen KJ, Ellis JA, et al. Genetic determinants of paediatric food allergy: a systematic review. Allergy. (2019) 74(9):1631–48. doi: 10.1111/all.13767
65. Winters A, Bahnson HT, Ruczinski I, Boorgula MP, Malley C, Keramati AR, et al. The Malt1 locus and peanut avoidance in the risk for peanut allergy. J Allergy Clin Immunol. (2019) 143(6):2326–9. doi: 10.1016/j.jaci.2019.02.016
66. Chang C, Wu H, Lu Q. The epigenetics of food allergy. Adv Exp Med Biol. (2020) 1253:141–52. doi: 10.1007/978-981-15-3449-2_5
67. Neeland MR, Martino DJ, Allen KJ. The role of gene-environment interactions in the development of food allergy. Expert Rev Gastroenterol Hepatol. (2015) 9(11):1371–8. doi: 10.1586/17474124.2015.1084873
68. Potaczek DP, Harb H, Michel S, Alhamwe BA, Renz H, Tost J. Epigenetics and allergy: from basic mechanisms to clinical applications. Epigenomics. (2017) 9(4):539–71. doi: 10.2217/epi-2016-0162
69. van Panhuys N, Le Gros G, McConnell MJ. Epigenetic regulation of Th2 cytokine expression in atopic diseases. Tissue Antigens. (2008) 72(2):91–7. doi: 10.1111/j.1399-0039.2008.01068.x
70. Bhat MI, Kapila R. Dietary metabolites derived from gut microbiota: critical modulators of epigenetic changes in mammals. Nutr Rev. (2017) 75(5):374–89. doi: 10.1093/nutrit/nux001
71. Schubeler D. Function and information content of DNA methylation. Nature. (2015) 517(7534):321–6. doi: 10.1038/nature14192
72. Weidner J, Bartel S, Kilic A, Zissler UM, Renz H, Schwarze J, et al. Spotlight on micrornas in allergy and asthma. Allergy. (2021) 76(6):1661–78. doi: 10.1111/all.14646
73. Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. (2019) 571(7766):489–99. doi: 10.1038/s41586-019-1411-0
74. Xu CJ, Gruzieva O, Qi C, Esplugues A, Gehring U, Bergstrom A, et al. Shared DNA methylation signatures in childhood allergy: the medall study. J Allergy Clin Immunol. (2021) 147(3):1031–40. doi: 10.1016/j.jaci.2020.11.044
75. Hollingsworth JW, Maruoka S, Boon K, Garantziotis S, Li ZW, Tomfohr J, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice (retracted article. See vol. 126, pg. 2012, 2016). J Clin Invest. (2008) 118(10):3462–9. doi: 10.1172/Jci34378
76. Peng C, Van Meel ER, Cardenas A, Rifas-Shiman SL, Sonawane AR, Glass KR, et al. Epigenome-wide association study reveals methylation pathways associated with childhood allergic sensitization. Epigenetics. (2019) 14(5):445–66. doi: 10.1080/15592294.2019.1590085
77. Hong X, Hao K, Ladd-Acosta C, ansen KD, Tsai HJ, Liu X, et al. Genome-wide association study identifies peanut allergy-specific loci and evidence of epigenetic mediation in US children. Nat Commun. (2015) 6:6304. doi: 10.1038/ncomms7304
78. Berni Canani R, Paparo L, Nocerino R, Cosenza L, Pezzella V, Di Costanzo M, et al. Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with Ige-mediated cow’s milk allergy. Clin Epigenetics. (2015) 7:38. doi: 10.1186/s13148-015-0070-8
79. Petrus NCM, Henneman P, Venema A, Mul A, van Sinderen F, Haagmans M, et al. Cow’s milk allergy in dutch children: an epigenetic pilot survey. Clin Transl Allergy. (2016) 6:16. doi: 10.1186/s13601-016-0105-z
80. Paparo L, Nocerino R, Cosenza L, Aitoro R, D'Argenio V, Del Monaco V, et al. Epigenetic features of Foxp3 in children with cow’s milk allergy. Clin Epigenetics. (2016) 8:86. doi: 10.1186/s13148-016-0252-z
81. Syed A, Garcia MA, Lyu SC, Bucayu R, Kohli A, Ishida S, et al. Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (Foxp3). J Allergy Clin Immunol. (2014) 133(2):500–10. doi: 10.1016/j.jaci.2013.12.1037
82. Krogulska A, Polakowska E, Wasowska-Krolikowska K, Malachowska B, Mlynarski W, Borowiec M. Decreased Foxp3 mrna expression in children with atopic asthma and Ige-mediated food allergy. Ann Allerg Asthma Im. (2015) 115(5):415–21. doi: 10.1016/j.anai.2015.08.015
83. Abbring S, Wolf J, Ayechu-Muruzabal V, Diks MAP, Alhamwe BA, Alhamdan F, et al. Raw cow’s milk reduces allergic symptoms in a murine model for food allergy-a potential role for epigenetic modifications. Nutrients. (2019) 11(8):1721. doi: 10.3390/nu11081721
84. van Esch B, Porbahaie M, Abbring S, Garssen J, Potaczek DP, Savelkoul HFJ, et al. The impact of milk and its components on epigenetic programming of immune function in early life and beyond: implications for allergy and asthma. Front Immunol. (2020) 11:2141. doi: 10.3389/fimmu.2020.02141
85. Okoye IS, Czieso S, Ktistaki E, Roderick K, Coomes SM, Pelly VS, et al. Transcriptomics identified a critical role for Th2 cell-intrinsic mir-155 in mediating allergy and antihelminth immunity. Proc Natl Acad Sci USA. (2014) 111(30):E3081–90. doi: 10.1073/pnas.1406322111
86. Melnik BC, John SM, Schmitz G. Milk: an exosomal microrna transmitter promoting thymic regulatory T cell maturation preventing the development of atopy? J Transl Med. (2014) 12:43. doi: 10.1186/1479-5876-12-43
87. Lu LF, Boldin MP, Chaudhry A, Lin LL, Taganov KD, Hanada T, et al. Function of mir-146a in controlling treg cell-mediated regulation of Th1 responses. Cell. (2010) 142(6):914–29. doi: 10.1016/j.cell.2010.08.012
88. D'Argenio V, Del Monaco V, Paparo L, De Palma FDE, Nocerino R, D'Alessio F, et al. Altered mir-193a-5p expression in children with cow’s milk allergy. Allergy. (2018) 73(2):379–86. doi: 10.1111/all.13299
89. Udemgba C, Lin A. B cells and food allergy. Curr Opin Pediatr. (2021) 33(6):625–32. doi: 10.1097/MOP.0000000000001050
90. Imran S, Neeland MR, Koplin J, Dharmage S, Tang ML, Sawyer S, et al. Epigenetic programming underpins B-cell dysfunction in peanut and multi-food allergy. Clin Transl Immunol. (2021) 10(8):e1324. doi: 10.1002/cti2.1324
91. Krajewski D, Kaczenski E, Rovatti J, Polukort S, Thompson C, Dollard C, et al. Epigenetic regulation via altered histone acetylation results in suppression of mast cell function and mast cell-mediated food allergic responses. Front Immunol. (2018) 9:2414. doi: 10.3389/fimmu.2018.02414
92. Zhou X, Han X, Lyu SC, Bunning B, Kost L, Chang I, et al. Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy. JCI Insight. (2021) 6(6):e143058. doi: 10.1172/jci.insight.143058
93. Fellows R, Varga-Weisz P. Chromatin dynamics and histone modifications in intestinal microbiota-host crosstalk. Mol Metab. (2020) 38:100925. doi: 10.1016/j.molmet.2019.12.005
94. Negi S, Das DK, Pahari S, Nadeem S, Agrewala JN. Potential role of gut microbiota in induction and regulation of innate immune memory. Front Immunol. (2019) 10:2441. doi: 10.3389/fimmu.2019.02441
95. Sestito S, D'Auria E, Baldassarre ME, Salvatore S, Tallarico V, Stefanelli E, et al. The role of prebiotics and probiotics in prevention of allergic diseases in infants. Front Pediatr. (2020) 8:583946. doi: 10.3389/fped.2020.583946
96. Zhao W, Ho HE, Bunyavanich S. The gut microbiome in food allergy. Ann Allergy Asthma Immunol. (2019) 122(3):276–82. doi: 10.1016/j.anai.2018.12.012
97. de LeBlanc AD, Dogi CA, Galdeano CM, Carmuega E, Weill R, Perdigon G. Effect of the administration of a fermented milk containing Lactobacillus Casei Dn-114001 on intestinal microbiota and gut associated immune cells of nursing mice and after weaning until immune maturity. BMC Immunol. (2008) 9:27. doi: 10.1186/1471-2172-9-27
98. Cortes-Perez NG, de Moreno de LeBlanc A, Gomez-Gutierrez JG, LeBlanc JG, Bermudez-Humaran LG. Probiotics and trained immunity. Biomolecules. (2021) 11(10):1402. doi: 10.3390/biom11101402
99. Mileti E, Matteoli G, Iliev ID, Rescigno M. Comparison of the immunomodulatory properties of three probiotic strains of lactobacilli using complex culture systems: prediction for in vivo efficacy. PLoS One. (2009) 4(9):e7056. doi: 10.1371/journal.pone.0007056
100. Paparo L, Nocerino R, Bruno C, Di Scala C, Cosenza L, Bedogni G, et al. Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow’s milk allergy: the epicma study (vol 9, 2828, 2019). Sci Rep-UK. (2019) 9:9504. doi: 10.1038/s41598-019-45226-8
101. Paparo L, Picariello G, Bruno C, Pisapia L, Canale V, Sarracino A, et al. Tolerogenic effect elicited by protein fraction derived from different formulas for dietary treatment of cow’s milk allergy in human cells. Front Immunol. (2021) 11:604075. doi: 10.3389/fimmu.2020.604075.
102. Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus Gg-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. (2016) 10(3):742–50. doi: 10.1038/ismej.2015.151
103. Davie JR. Inhibition of histone deacetylase activity by butyrate. J Nutr. (2003) 133(7 Suppl):2485S–93S. doi: 10.1093/jn/133.7.2485S
104. Tao R, de Zoeten EF, Ozkaynak E, Chen C, Wang L, Porrett PM, et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med. (2007) 13(11):1299–307. doi: 10.1038/nm1652
105. Penkov S, Mitroulis I, Hajishengallis G, Chavakis T. Immunometabolic crosstalk: an ancestral principle of trained immunity? Trends Immunol. (2019) 40(1):1–11. doi: 10.1016/j.it.2018.11.002
106. Lundahl MLE, Mitermite M, Ryan DG, Case S, Williams NC, Yang M, et al. Macrophage innate training induced by Il-4 and Il-13 activation enhances oxphos driven anti-mycobacterial responses. eLife. (2022) 11:e74690. doi: 10.7554/eLife.74690
107. Van den Bossche J, Baardman J, Otto NA, van der Velden S, Neele AE, van den Berg SM, et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. (2016) 17(3):684–96. doi: 10.1016/j.celrep.2016.09.008
108. Martino D, Neeland M, Dang T, Cobb J, Ellis J, Barnett A, et al. Epigenetic dysregulation of naive Cd4+ T-cell activation genes in childhood food allergy. Nat Commun. (2018) 9(1):3308. doi: 10.1038/s41467-018-05608-4
109. Hong X, Ladd-Acosta C, Hao K, Sherwood B, Ji H, Keet CA, et al. Epigenome-wide association study links site-specific DNA methylation changes with cow’s milk allergy. J Allergy Clin Immunol. (2016) 138(3):908–11.e9. doi: 10.1016/j.jaci.2016.01.056
110. Khader SA, Divangahi M, Hanekom W, Hill PC, Maeurer M, Makar KW, et al. Targeting innate immunity for tuberculosis vaccination. J Clin Invest. (2019) 129(9):3482–91. doi: 10.1172/JCI128877
111. Sebastian C, Vong JSL, Mayekar MK, Tummala KS, Singh I. Editorial: metabolism and epigenetics. Front Genet. (2022) 13:877538. doi: 10.3389/fgene.2022.877538
112. Tulaeva I, Kratzer B, Campana R, Curin M, van Hage M, Karsonova A, et al. Preventive allergen-specific vaccination against allergy: mission possible? Front Immunol. (2020) 11:1368. doi: 10.3389/fimmu.2020.01368
113. Blok BA, Arts RJW, van Crevel R, Benn CS, Netea MG. Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines. J Leukocyte Biol. (2015) 98(3):347–56. doi: 10.1189/jlb.5RI0315-096R
114. Sanchez-Ramon S, Conejero L, Netea MG, Sancho D, Palomares O, Subiza JL. Trained immunity-based vaccines: a new paradigm for the development of broad-spectrum anti-infectious formulations. Front Immunol. (2018) 9:2936. doi: 10.3389/fimmu.2018.02936
115. Libraty DH, Zhang L, Woda M, Acosta LP, Obcena A, Brion JD, et al. Neonatal Bcg vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines. Trials Vaccinol. (2014) 3:1–5. doi: 10.1016/j.trivac.2013.11.004
116. Gouveia AC, Brugiolo AS, Alves CC, Silva FM, Mesquita FP, Gameiro J, et al. Th2 responses in ova-sensitized Balb/C mice are down-modulated by Mycobacterium Bovis Bcg treatment. J Clin Immunol. (2013) 33(1):235–45. doi: 10.1007/s10875-012-9746-4
117. Linehan MF, Nurmatov U, Frank TL, Niven RM, Baxter DN, Sheikh A. Does Bcg vaccination protect against childhood asthma? Final results from the manchester community asthma study retrospective cohort study and updated systematic review and meta-analysis. J Allergy Clin Immunol. (2014) 133(3):688–95.e14. doi: 10.1016/j.jaci.2013.08.007
118. Thostesen LM, Stensballe LG, Pihl GT, Kjaergaard J, Birk NM, Nissen TN, et al. Neonatal Bcg vaccination has no effect on recurrent wheeze in the first year of life: a randomized clinical trial. J Allergy Clin Immunol. (2017) 140(6):1616–21.e3. doi: 10.1016/j.jaci.2016.12.990
119. Thostesen LM, Kjaer HF, Pihl GT, Nissen TN, Birk NM, Kjaergaard J, et al. Neonatal Bcg has no effect on allergic sensitization and suspected food allergy until 13 months. Pediatr Allergy Immunol. (2017) 28(6):588–96. doi: 10.1111/pai.12748
120. Estcourt MJ, Campbell DE, Gold MS, Richmond P, Allen KJ, Quinn HE, et al. Whole-cell pertussis vaccination and decreased risk of ige-mediated food allergy: a nested case-control study. J Allergy Clin Immunol Pract. (2020) 8(6):2004–14. doi: 10.1016/j.jaip.2019.12.020
121. Benito-Villalvilla C, Perez-Diego M, Angelina A, Kisand K, Rebane A, Subiza JL, et al. Allergoid-mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring. J Allergy Clin Immun. (2022) 149(1):212. doi: 10.1016/j.jaci.2021.06.012
122. Benito-Villalvilla C, Perez-Diego M, Subiza JL, Palomares O. Allergoid-mannan conjugates imprint tolerogenic features in human macrophages. Allergy. (2022) 77(1):320–3. doi: 10.1111/all.15118
123. Shamji MH, Sharif H, Layhadi JA, Zhu RF, Kishore U, Renz H. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma. J Allergy Clin Immun. (2022) 149(3):791–801. doi: 10.1016/j.jaci.2022.01.016
124. Golebski K, Layhadi JA, Sahiner U, Steveling-Klein EH, Lenormand MM, Li RCY, et al. Induction of Il-10-producing type 2 innate lymphoid cells by allergen immunotherapy is associated with clinical response. Immunity. (2021) 54(2):291. doi: 10.1016/j.immuni.2020.12.013
Keywords: food allergy, trained immunity, microbiota, epigenetic, metabolic reprogramming
Citation: Arzola-Martínez L, Ptaschinski C and Lukacs NW (2023) Trained innate immunity, epigenetics, and food allergy. Front. Allergy 4:1105588. doi: 10.3389/falgy.2023.1105588
Received: 22 November 2022; Accepted: 10 May 2023;
Published: 26 May 2023.
Edited by:
Joseph Dolence, University of Nebraska at Kearney, United StatesReviewed by:
Annette Kuehn, Luxembourg Institute of Health, LuxembourgGizem Kilic, Radboud University Medical Centre, Netherlands
© 2023 Arzola-Martínez, Ptaschinski and Lukacs. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Nicholas W. Lukacs bmx1a2Fjc0BtZWQudW1pY2guZWR1